A living WHO guideline on drugs to prevent covid-19

F Lamontagne, M Stegemann, A Agarwal, T Agoritsas… - bmj, 2021 - bmj.com
Clinical question What is the role of drugs in preventing covid-19? Why does this matter?
There is widespread interest in whether drug interventions can be used for the prevention of …

The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials

K Thorlund, D Smith, C Linsell, N White… - Communications …, 2023 - nature.com
Clinical trial endpoints must be carefully and intentionally selected so that the results of the
trial can be used to inform policy-and decision-making. The relative importance of potential …

Favipiravir and ivermectin show in vitro synergistic antiviral activity against SARS-CoV-2

K Jitobaom, C Boonarkart… - Acta …, 2023 - frontierspartnerships.org
Despite the urgent need for effective antivirals against SARS-CoV-2 to mitigate the
catastrophic impact of the COVID-19 pandemic, favipiravir and ivermectin are among the …

Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match

M Cokljat, CV Cruz, VI Carrara, K Puttaraska… - BMJ Global …, 2024 - gh.bmj.com
Background The COVID-19 pandemic affected all WHO member states. We compared and
contrasted the COVID-19 treatment guidelines of each member state with the WHO COVID …

WHO COVID-19 therapeutic guidelines–Authors' reply

NJ White, N Strub-Wourgaft, A Faiz, PJ Guerin - The Lancet, 2021 - thelancet.com
We thank Bram Rochwerg and colleagues for information on the WHO therapeutic guideline
development process. Unfortunately, they do not address our main concern: the unjustified …

[HTML][HTML] Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study

C Perrone, W Schilling, JJ Callery… - Wellcome Open …, 2021 - ncbi.nlm.nih.gov
Background: The COPCOV study (chloroquine/hydroxychloroquine prevention of
coronavirus disease), which started recruitment in April 2020, is a multi-country double …

[HTML][HTML] Does Widespread Use of Hydroxychloroquine Reduce the Transmissibility of SARS-CoV-2/COVID-19? An Ecological Correlational Study

FS Neves - Infectious Disorders Drug Targets, 2023 - ncbi.nlm.nih.gov
Background At the beginning of the coronavirus disease (COVID-19) pandemic,
hydroxychloroquine (HCQ) was widely used as a possible antiviral agent. Current …

[PDF][PDF] Médicaments visant à prévenir la COVID-19: orientations évolutives, 24 mars 2023

O mondiale de la Santé - 2023 - apps.who.int
Aux termes de cette licence, vous pouvez copier, distribuer et adapter l'œuvre à des fins non
commerciales, pour autant que l'œuvre soit citée de manière appropriée, comme il est …

[HTML][HTML] CONTROLE SOCIAL, TRANSPARÊNCIA, INTEIREZA CIENTÍFICA E RESPONSABILIDADE EM PESQUISAS MÉDICAS

F Dantas - 2023 - europepmc.org
Abstract The CEP/CONEP System, submitted to social control, is responsible for the ethical
approval of research in Brazil to protect research participants. The Informed Consent Form …

COVID-19 chemoprevention

C Cruz, NJ White - International Journal of Infectious Diseases, 2021 - ijidonline.com
Despite the enormity of COVID-19 pandemic and the many hundreds of clinical trials
evaluating putative therapeutics, there have been very few randomised controlled trials …